Topic: Abilify
Otsuka Pharmaceutical Co. Ltd. said a federal court ruled Monday that patents protecting the active ingredient behind the schizophrenia drug Abilify are valid and enforceable.. Otsuka discovered Abilify, which is approved for schizophrenia, bipolar disorder and depression. Shares of Bristol-Myers fell 24 ...
The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday. Abilify is Bristol-Myers' second-biggest revenue generator, with $2.2 billion in ...
CHICAGO (Reuters) - Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said on ...
Bristol-Myers Squibb Co.(BMY) Q3 2009 Earnings Call October 22, 2009 10:30 am ET. For example, PLAVIX grew 9% globally, ex-Foreign exchange, despite the launch of Lilly's Efient. Our U.S. sales grew 12% to $3 billion compared to last year and internationally our ...
Bristol-Myers faces growing competition for key drugs as it reports 3Q resultsBristol-Myers Squibb Co., the world's No. 15 drug maker by revenue, reports earnings for the third quarter on Thursday morning. Johnson's Xarelto got a favorable review from FDA advisers in March, ...
The best secret to keep in mind related to the field of medicines is that these medicines are easily available for everyone. The chief secret is that you can take delivery of your prescriptions for absolutely free. All of us are aware ...
BMY) today announced first quarter results which included excellent financial performance and successful execution of two key strategic initiatives. Bristol-Myers Squibb retains 83% ownership of Mead Johnson, providing the company with financial diversification while enhancing management focus on the BioPharma business.. Bristol-Myers ...
"The announcement today is further evidence that Bristol-Myers Squibb is delivering on its commitments to advance its transformation to a leading next-generation BioPharma," said Lamberto Andreotti, president and chief operating officer, Bristol-Myers Squibb. Under terms of the agreement Bristol-Myers Squibb will pay ...
com guide to bipolar disorder shares a story on her blog that shows us exactly what big pharma is all about. Or, if you've been dieting for years, then you know that drugs like Redux and Phen-Fen were pulled many years ago. ...
Bristol Myers Squibb Company (BMY) Q3 FY08 Earnings Call October 23, 2008 10:30 am ET. On a non-GAAP basis, we grew diluted earnings per share from continuing operations 39% in the quarter or $0.46, which was $0.04 ahead of consensus estimates. Also ...
From Around the Web
Video Gallery
-
ABILIFY® (aripiprazole) Anti-Depressant Add-on Tr...
The most current video on using Abilify as an addon ...2011-02-27 -
Abilify Kills
Andy Behrman, a former spokesman for Abilify and Bristol Myers ...2009-05-14 -
Treating Depression by Adding ABILIFY® aripiprazo...
This is the newest Abilify for depression commercial from the ...2009-03-18
